About Regulus Therapeutics

Regulus Therapeutics Inc. or Regulus (NASDAQ: RGLS) is a biopharmaceutical company focused on the development of microRNA-based drugs targeting fibrosis, metabolism and cardiovascular diseases, cancer, HCV and immune-related diseases. Regulus was established in September 2007 by Alnylam Pharmaceuticals and Isis Pharmaceuticals.–Wikipedia

Reviews

Overall

4.0
Based on 2 reviews
5 stars
4 stars
3 stars
2 stars
1 star
Work/Life Balance
4.0
Compensation/Benefits
5.0
Job Security/Advancement
4.0
Management
4.0
Culture
3.0
Claim this company page
Headquarters
San Diego, California, USA
Links
Regulus Therapeutics website